[go: up one dir, main page]

ITTO920303A1 - Composizione farmaceutica antiinfiammatoria - Google Patents

Composizione farmaceutica antiinfiammatoria

Info

Publication number
ITTO920303A1
ITTO920303A1 IT92TO000303A ITTO920303A ITTO920303A1 IT TO920303 A1 ITTO920303 A1 IT TO920303A1 IT 92TO000303 A IT92TO000303 A IT 92TO000303A IT TO920303 A ITTO920303 A IT TO920303A IT TO920303 A1 ITTO920303 A1 IT TO920303A1
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
antiinflammatory pharmaceutical
antiinflammatory
micronized
active component
Prior art date
Application number
IT92TO000303A
Other languages
English (en)
Inventor
Sung J Lee
Original Assignee
Biofor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofor Ltd filed Critical Biofor Ltd
Publication of ITTO920303A0 publication Critical patent/ITTO920303A0/it
Publication of ITTO920303A1 publication Critical patent/ITTO920303A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Una composizione antiinfiammatoria in cui il componente attivo sia micronizzato in modo da formare una miscela intima somministrabile per via orale.
IT92TO000303A 1991-04-05 1992-04-02 Composizione farmaceutica antiinfiammatoria ITTO920303A1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/680,997 US5271944A (en) 1991-04-05 1991-04-05 Pharmacologically enhanced formulations

Publications (2)

Publication Number Publication Date
ITTO920303A0 ITTO920303A0 (it) 1992-04-02
ITTO920303A1 true ITTO920303A1 (it) 1993-10-02

Family

ID=24733350

Family Applications (1)

Application Number Title Priority Date Filing Date
IT92TO000303A ITTO920303A1 (it) 1991-04-05 1992-04-02 Composizione farmaceutica antiinfiammatoria

Country Status (16)

Country Link
US (1) US5271944A (it)
EP (1) EP0599914B1 (it)
AT (1) ATE155687T1 (it)
AU (1) AU1876792A (it)
CA (1) CA2052901C (it)
CH (1) CH683824A5 (it)
DE (1) DE69221150T2 (it)
DK (1) DK0599914T3 (it)
ES (1) ES2108130T3 (it)
FR (1) FR2674754B1 (it)
IE (1) IE74211B1 (it)
IT (1) ITTO920303A1 (it)
NZ (1) NZ242233A (it)
PT (1) PT100329B (it)
WO (1) WO1992017163A1 (it)
ZA (1) ZA922482B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
DK0812195T3 (da) * 1995-02-28 2003-03-03 Aventis Pharma Inc Farmaceutisk sammensætning til piperidinoalkanolforbindelser
CZ295461B6 (cs) * 1997-08-26 2005-08-17 Aventis Pharmaceuticals Inc. Farmaceutický prostředek ve formě dvouvrstvé tablety
EP1600159A1 (en) 2000-04-24 2005-11-30 Teva Pharmaceutical Industries Ltd A method for synthesizing different Zolpidem hemitartrate derivatives
PT1473036E (pt) * 2000-04-24 2006-10-31 Teva Pharma Solvato de hemitartarato de zolpidem
EP2135611A1 (en) 2001-03-01 2009-12-23 Hollis-Eden Pharmaceuticals Inc. Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy
US20060280761A1 (en) * 2002-03-11 2006-12-14 Health Plus International, Inc. Nanofluidized B-12 composition and process for treating pernicious anemia
US6861066B2 (en) * 2002-03-11 2005-03-01 Health Plus International Inc. Method for the delivery of a biologically active agent
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
EP1685126B1 (en) * 2003-10-16 2007-03-21 Teva Pharmaceutical Industries Limited Preparation of candesartan cilexetil
WO2005067936A2 (en) * 2004-01-05 2005-07-28 Teva Pharmaceutical Industries Ltd. Methods for the production of sildenafil base and citrate salt
EP1713795A2 (en) * 2004-02-11 2006-10-25 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
CA2582231A1 (en) 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals, Inc. Steroid analogs and uses
JP2011527986A (ja) 2008-04-03 2011-11-10 ハーバー バイオサイエンシーズ，インコーポレイテッド 医薬の固体状態形態
TW201613888A (en) * 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3204126A1 (de) * 1982-02-06 1983-08-11 Bayer Ag, 5090 Leverkusen Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4912093A (en) * 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DE3723327A1 (de) * 1987-07-15 1989-02-02 Hoechst Ag Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
US4892870A (en) * 1988-08-01 1990-01-09 Biofor, Ltd. Oxaza heterocycles and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
EP0599914A4 (en) 1994-08-24
AU1876792A (en) 1992-11-02
WO1992017163A1 (en) 1992-10-15
EP0599914A1 (en) 1994-06-08
PT100329B (pt) 1999-06-30
CA2052901A1 (en) 1992-10-06
ITTO920303A0 (it) 1992-04-02
ATE155687T1 (de) 1997-08-15
CA2052901C (en) 1997-12-23
PT100329A (pt) 1993-07-30
FR2674754A1 (fr) 1992-10-09
FR2674754B1 (fr) 1994-01-14
US5271944A (en) 1993-12-21
NZ242233A (en) 1993-07-27
CH683824A5 (de) 1994-05-31
ZA922482B (en) 1992-12-30
DK0599914T3 (da) 1998-03-02
DE69221150D1 (de) 1997-09-04
IE74211B1 (en) 1997-07-16
IE921040A1 (en) 1992-10-07
DE69221150T2 (de) 1998-02-26
EP0599914B1 (en) 1997-07-23
ES2108130T3 (es) 1997-12-16

Similar Documents

Publication Publication Date Title
ITTO920303A1 (it) Composizione farmaceutica antiinfiammatoria
CR6210A (es) Composiciones de celecoxib
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
NO305537B1 (no) Farmas°ytisk preparat inneholdene et definert lipidsystem, og anvendelse av lipidsystemet
ES2061094T3 (es) Un procedimiento para la obtencion de una formulacion para disminuir el deseo imperioso de alcohol (craving) en el tratamiento del alcoholismo cronico.
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
ATE250034T1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
KR910005858A (ko) 지방산 요법
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
NO975127L (no) Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
ATE44461T1 (de) Analgetische zusammensetzungen.
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
ATE82849T1 (de) Dextrorphansalze enthaltende orale arzneimittel.
NO974956L (no) Terapeutisk sammensetning for artritis
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
SE8104675L (sv) Farmacevtisk komposition med antiflogistisk, antipyretisk och analgetisk verkan
CO4790092A1 (es) Granisetron para tratamiento de la diarrea
KR830005856A (ko) 소염, 해열 및 진통제 조성물
JPS5251032A (en) Medicines of disaccharide-glutathione derivatives
JPS55136228A (en) Novel antiallergic agent
CO4370015A1 (es) Formulacion farmaceutica comprendiendo amoxicilina y potasio de clavulanato

Legal Events

Date Code Title Description
0002 Rejected